FDA pushes for development of non-opioid pain medications

By Laurie McGinley  

The Food and Drug Administration is planning new steps to encourage the development of nonaddictive alternatives to opioid pain medications, Commissioner Scott Gottlieb said in an interview.

As part of the effort, the agency plans to withdraw its existing 2014 guidance to the drug industry on pain medicines. That document is overly broad, Gottlieb said, and is sometimes a barrier to new products and innovations. The current guidelines call for a large number of studies to get FDA approval for general use for chronic pain, he added.

Learn more>>>https://www.washingtonpost.com/news/to-your-health/wp/2018/08/29/fda-pushes-for-development-of-non-opioid-pain-medications/?noredirect=on&utm_term=.aba539ed9102